Sort
48,018 grants matching “immunotherapy”
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
$395,984Natasha Diba Sheybani · University Of Virginia · DP5 · FY2023 · OD
Bispecific Antibody-Based PET Ligands for Imaging Tauopathies
$395,984Yu-Shin Ding · New York University School Of Medicine · R21 · FY2020 · AG
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$395,960Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2015 · NS
IL-27-mediated immunoregulation in HSV-1-induced stromal keratitis
$395,927Amol Suryawanshi · Auburn University At Auburn · R01 · FY2023 · EY
Microcarrier / CEF / Media SYSTEM to make Viral Vaccines
$395,902Solohill Engineering, Inc. · R44 · FY2001 · AI
The Role of HBeAg in HBV Persistence
$395,844Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Untangling the role of dopamine release from Tregs: implications for neurodegeneration at the neuron-immune synapse
$395,837Ashley E Ross · University Of Cincinnati · R21 · FY2024 · AG
Development of murine glioblastoma model for oncolytic HSV therapy
$395,812Balveen Kaur · Augusta University · R61 · FY2024 · NS
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis
$395,776Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2023 · AI
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2021 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2019 · CA
Discovery & Validation of Biomarkers of Kidney Pathology
$395,740Brad H Rovin · Ohio State University · U01 · FY2017 · DK
Development of Therapeutic Cancer Vaccine
$395,738Haifa Shen · Immunoq Therapeutics Inc. · R41 · FY2022 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$395,738Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy
$395,733Yingxiao Wang · University Of California, San Diego · R01 · FY2021 · EB
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
$395,712Natasha Diba Sheybani · University Of Virginia · DP5 · FY2024 · OD
Telomerase RNA Transfected Dendritic Cell Vaccines
$395,707Duke University · R01 · FY2003 · CA
Elucidating the role of T-regs in engraftment, GVHD, and DLI immunotherapy
$395,697Christene A Huang · Massachusetts General Hospital · R01 · FY2013 · AI
Targeting the Vgf signaling system for new chronic pain treatments
$395,600Lyudmila H Vulchanova · University Of Minnesota · R21 · FY2019 · NS
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$395,597Boris Reizis · Columbia University Health Sciences · R01 · FY2014 · AI
Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers
$395,595Marcus Laird Forrest · Kinimmune, Inc. · R41 · FY2022 · CA
Sex specific epigenetic regulation of colon cancer metastasis
$395,576Y. Alan Wang · Indiana University Indianapolis · R01 · FY2023 · CA
University of Maryland Greenebaum Cancer Center Support Grant
$395,573Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2015 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$395,516Minah Kim · Columbia University Health Sciences · R37 · FY2024 · CA